Targeted Therapies in Oncology
January I, 2024
Volume: 13
Issue: 1
December II, 2023
Volume: 12
Issue: 18
December I, 2023
Volume: 12
Issue: 17
November II, 2023
Volume: 12
Issue: 16
November I, 2023
Volume: 12
Issue: 15
October II, 2023
Volume: 12
Issue: 14
October I
Volume: 12
Issue: 13
September I
Volume: 12
Issue: 12
August I
Volume: 12
Issue: 11
July 1, 2023
Volume: 12
Issue: 9
July II, 2023
Volume: 12
Issue: 10
June 2023
Volume: 12
Issue: 8
May 2023
Volume: 12
Issue: 7
April 2, 2023
Volume: 12
Issue: 6
April 1, 2023
Volume: 12
Issue: 5
March 1, 2023
Volume: 12
Issue: 3
February 2023
Volume: 12
Issue: 2
January 2023
Volume: 11
Issue: 17
December 2, 2022
Volume: 11
Issue: 18
December 1, 2022
Volume: 11
Issue: 17
November 2, 2022
Volume: 11
Issue: 16
November 1, 2022
Volume: 11
Issue: 15
October 1, 2022
October 2, 2022
Volume: 11
Issue: 14
September 2022
Volume: 11
Issue: 12
August 2022
Volume: 11
Issue: 11
July 1, 2022
Volume: 11
Issue: 9
July 2, 2022
Volume: 11
Issue: 10
June 1, 2022
Volume: 11
Issue: 8
May 2022
Volume: 11
Issue: 7
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
3
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
4
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
5
